Sign in Subscribe

Latest

Daytrip road trips are more than point A to point B

Surveys found 78% of travelers looked for at least one memorable, locally authentic experience when planning their 2026 trips. Travelers increasingly want more from their vacations and are willing to pay extra to get that experience. That desire helps fuel the growth of Daytrip, a global travel platform that recently

NEURELIS CEO CRAIG CHAMBLISS NAMED EY US ENTREPRENEUR OF THE YEAR® 2026 PACIFIC SOUTHWEST AWARD WINNER

NEURELIS CEO CRAIG CHAMBLISS NAMED EY US ENTREPRENEUR OF THE YEAR® 2026 PACIFIC SOUTHWEST AWARD WINNER

Recognition honors business leaders for their ingenuity, courage, and entrepreneurial spirit SAN DIEGO, June 15, 2026 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced its Founder and Chief Executive Officer Craig Chambliss was named an Ernst & Young LLP (EY US) Entrepreneur Of The Year® 2026

Residence Adds GateMaker, Bringing Creator Economy Expertise to Its Growing Creative Network

LOS ANGELES, June 15, 2026 /PRNewswire/ -- Residence, the global network of creative companies, has brought on GateMaker, a 360° influencer marketing agency helping global brands dominate on social media through paid, earned, and owned creator relationships. GateMaker's addition to Residence adds a new dimension to what the network

Residence Adds GateMaker, Bringing Creator Economy Expertise to Its Growing Creative Network

LOS ANGELES, June 15, 2026 /PRNewswire/ -- Residence, a portfolio company of Gemspring Capital and a global network of creative companies, announced today that GateMaker, a 360-degree influencer marketing agency helping global brands build paid, earned, and owned creator relationships, has joined Residence's growing creative network. The addition

Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs

* TruCan Ultra Lyme-L4 is the first and only 1/2 mL combination vaccine protecting against both Lyme disease and leptospirosis, all in a low-volume dose * By combining two injections into one, the vaccine minimizes "pokes" supporting comfortable wellness visits for pets * Features proprietary PureFil™ Technology, designed

Molex Expands Award-Winning AirBorn SInergy Modular High-Speed Hybrid Connectors with New High-Power Modules for All-in-One Connectivity

Molex Expands Award-Winning AirBorn SInergy Modular High-Speed Hybrid Connectors with New High-Power Modules for All-in-One Connectivity

* Ability to mix-and-match high-power, high-speed data and RF contacts meets multiple demands of high-performance systems and space-constrained device challenges * Versatile and configurable modules address aerospace, defense and space requirements for durability and signal strength in extreme environments * Hybrid connector framework streamlines system integration, design

Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026

Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026

* Two-year CRENESSITY data in adults showed improvements in cardiometabolic outcomes of insulin resistance, body composition and body weight alongside sustained reductions in glucocorticoid dose * Among participants who were overweight or obese at baseline, 37% achieved >5% reduction in body weight at 2 years, and 43% of those with